Annual EBITDA
-$122.54 M
-$31.65 M-34.82%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual EBITDA is -$122.54 million, with the most recent change of -$31.65 million (-34.82%) on December 31, 2023.
- During the last 3 years, VOR annual EBITDA has fallen by -$79.78 million (-186.58%).
- VOR annual EBITDA is now -3816.40% below its all-time high of -$3.13 million, reached on December 31, 2018.
Performance
VOR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$27.66 M
+$504.00 K+1.79%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly EBITDA is -$27.66 million, with the most recent change of +$504.00 thousand (+1.79%) on September 30, 2024.
- Over the past year, VOR quarterly EBITDA has dropped by -$430.00 thousand (-1.58%).
- VOR quarterly EBITDA is now -618.12% below its all-time high of -$3.85 million, reached on December 31, 2019.
Performance
VOR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$114.44 M
+$6.76 M+5.58%
September 30, 2024
Summary
- As of February 8, 2025, VOR TTM EBITDA is -$114.44 million, with the most recent change of +$6.76 million (+5.58%) on September 30, 2024.
- Over the past year, VOR TTM EBITDA has increased by +$8.10 million (+6.61%).
- VOR TTM EBITDA is now -2871.00% below its all-time high of -$3.85 million, reached on December 31, 2019.
Performance
VOR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VOR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.8% | -1.6% | +6.6% |
| 3 y3 years | -186.6% | -1.6% | +6.6% |
| 5 y5 years | -3816.4% | -1.6% | +6.6% |
VOR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.3% | at low | -54.4% | +19.6% | -69.3% | +8.0% |
| 5 y | 5-year | -1108.5% | at low | -618.1% | +19.6% | -2871.0% | +8.0% |
| alltime | all time | -3816.4% | at low | -618.1% | +19.6% | -2871.0% | +8.0% |
Vor Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.66 M(-1.8%) | -$114.44 M(-5.6%) |
| Jun 2024 | - | -$28.17 M(-10.3%) | -$121.20 M(-2.5%) |
| Mar 2024 | - | -$31.38 M(+15.2%) | -$124.34 M(+1.5%) |
| Dec 2023 | -$122.54 M(+34.8%) | -$27.23 M(-20.9%) | -$122.54 M(+2.6%) |
| Sep 2023 | - | -$34.42 M(+10.0%) | -$119.41 M(+9.5%) |
| Jun 2023 | - | -$31.30 M(+5.8%) | -$109.08 M(+11.7%) |
| Mar 2023 | - | -$29.59 M(+22.8%) | -$97.69 M(+8.0%) |
| Dec 2022 | -$90.89 M | -$24.09 M(-0.0%) | -$90.47 M(+7.3%) |
| Sep 2022 | - | -$24.10 M(+21.1%) | -$84.29 M(+7.5%) |
| Jun 2022 | - | -$19.91 M(-11.0%) | -$78.42 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$22.37 M(+24.9%) | -$76.54 M(+13.3%) |
| Dec 2021 | -$67.58 M(+58.1%) | -$17.91 M(-1.7%) | -$67.58 M(+3.8%) |
| Sep 2021 | - | -$18.23 M(+1.1%) | -$65.09 M(+11.3%) |
| Jun 2021 | - | -$18.03 M(+34.3%) | -$58.46 M(+20.9%) |
| Mar 2021 | - | -$13.42 M(-13.0%) | -$48.37 M(+13.1%) |
| Dec 2020 | -$42.76 M(+321.7%) | -$15.42 M(+33.0%) | -$42.76 M(+37.1%) |
| Sep 2020 | - | -$11.59 M(+46.1%) | -$31.19 M(+59.2%) |
| Jun 2020 | - | -$7.93 M(+1.6%) | -$19.60 M(+68.0%) |
| Mar 2020 | - | -$7.81 M(+102.8%) | -$11.66 M(+202.8%) |
| Dec 2019 | -$10.14 M(+224.1%) | -$3.85 M | -$3.85 M |
| Dec 2018 | -$3.13 M | - | - |
FAQ
- What is Vor Biopharma annual EBITDA?
- What is the all time high annual EBITDA for Vor Biopharma?
- What is Vor Biopharma annual EBITDA year-on-year change?
- What is Vor Biopharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vor Biopharma?
- What is Vor Biopharma quarterly EBITDA year-on-year change?
- What is Vor Biopharma TTM EBITDA?
- What is the all time high TTM EBITDA for Vor Biopharma?
- What is Vor Biopharma TTM EBITDA year-on-year change?
What is Vor Biopharma annual EBITDA?
The current annual EBITDA of VOR is -$122.54 M
What is the all time high annual EBITDA for Vor Biopharma?
Vor Biopharma all-time high annual EBITDA is -$3.13 M
What is Vor Biopharma annual EBITDA year-on-year change?
Over the past year, VOR annual EBITDA has changed by -$31.65 M (-34.82%)
What is Vor Biopharma quarterly EBITDA?
The current quarterly EBITDA of VOR is -$27.66 M
What is the all time high quarterly EBITDA for Vor Biopharma?
Vor Biopharma all-time high quarterly EBITDA is -$3.85 M
What is Vor Biopharma quarterly EBITDA year-on-year change?
Over the past year, VOR quarterly EBITDA has changed by -$430.00 K (-1.58%)
What is Vor Biopharma TTM EBITDA?
The current TTM EBITDA of VOR is -$114.44 M
What is the all time high TTM EBITDA for Vor Biopharma?
Vor Biopharma all-time high TTM EBITDA is -$3.85 M
What is Vor Biopharma TTM EBITDA year-on-year change?
Over the past year, VOR TTM EBITDA has changed by +$8.10 M (+6.61%)